Literature DB >> 21801689

Concerns regarding sacral neuromodulation as a treatment option for medical-refractory overactive bladder.

Daniel Liberman1, Luc Valiquette.   

Abstract

Year:  2011        PMID: 21801689      PMCID: PMC3147046          DOI: 10.5489/cuaj.11043

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  18 in total

1.  Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group.

Authors:  R A Schmidt; U Jonas; K A Oleson; R A Janknegt; M M Hassouna; S W Siegel; P E van Kerrebroeck
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

2.  Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland.

Authors:  Thomas M Kessler; Eric Buchser; Sylvain Meyer; Daniel S Engeler; Abdul-Wahab Al-Khodairy; Ulf Bersch; Christophe E Iselin; Bruno Roche; Daniel M Schmid; Brigitte Schurch; Stephane Zrehen; Fiona C Burkhard
Journal:  Eur Urol       Date:  2006-11-13       Impact factor: 20.096

3.  Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study.

Authors:  A C van Voskuilen; D J A J Oerlemans; E H J Weil; R A de Bie; Ph E V A van Kerrebroeck
Journal:  Eur Urol       Date:  2006-01-04       Impact factor: 20.096

Review 4.  Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence.

Authors:  P Abrams; K E Andersson; L Birder; L Brubaker; L Cardozo; C Chapple; A Cottenden; W Davila; D de Ridder; R Dmochowski; M Drake; C Dubeau; C Fry; P Hanno; J Hay Smith; S Herschorn; G Hosker; C Kelleher; H Koelbl; S Khoury; R Madoff; I Milsom; K Moore; D Newman; V Nitti; C Norton; I Nygaard; C Payne; A Smith; D Staskin; S Tekgul; J Thuroff; A Tubaro; D Vodusek; A Wein; J J Wyndaele
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

5.  Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety.

Authors:  M M Hassouna; S W Siegel; A A Nÿeholt; M M Elhilali; P E van Kerrebroeck; A K Das; J B Gajewski; R A Janknegt; D A Rivas; H Dijkema; D F Milam; K A Oleson; R A Schmidt
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

6.  Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention.

Authors:  S W Siegel; F Catanzaro; H E Dijkema; M M Elhilali; C J Fowler; J B Gajewski; M M Hassouna; R A Janknegt; U Jonas; P E van Kerrebroeck; A A Lycklama a Nijeholt; K A Oleson; R A Schmidt
Journal:  Urology       Date:  2000-12-04       Impact factor: 2.649

7.  National trends in the usage and success of sacral nerve test stimulation.

Authors:  Anne P Cameron; Jennifer T Anger; Rodger Madison; Christopher S Saigal; J Quentin Clemens
Journal:  J Urol       Date:  2011-01-19       Impact factor: 7.450

8.  Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center.

Authors:  Ali A Al-zahrani; Ehab A Elzayat; Jerzy B Gajewski
Journal:  J Urol       Date:  2011-01-19       Impact factor: 7.450

9.  Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial.

Authors:  Roger Dmochowski; Christopher Chapple; Victor W Nitti; Michael Chancellor; Karel Everaert; Catherine Thompson; Grace Daniell; Jihao Zhou; Cornelia Haag-Molkenteller
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

Review 10.  Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review.

Authors:  Miriam Brazzelli; Alison Murray; Cynthia Fraser
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

View more
  2 in total

1.  Overactive bladder, differential diagnosis, and clinical utility of fesoterodine.

Authors:  Jean-Jacques Wyndaele
Journal:  Int J Gen Med       Date:  2012-11-12

Review 2.  Neuromodulation - a therapeutic option for refractory overactive bladder. A recent literature review.

Authors:  Jacek K Szymański; Aneta Słabuszewska-Jóźwiak; Kornelia Zaręba; Grzegorz Jakiel
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-05-23       Impact factor: 1.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.